The Breath Of Life Thanks To A Chip
THE SEARCH FOR BETTER ways to deliver drug treatments is a critical issue in asthma, a chronic respiratory ailment that affects 15 million people in the U.S. and kills 5,000 each year. Although vastly improved asthma drugs have been introduced in recent years, they must still be breathed in through small devices called metered-dose inhalers (MDIs) that are notoriously tricky to use. Patients must carefully coordinate their breathing with the pumping action to ensure the right dosage--a technique that 70% of asthmatics fail to master.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Tesla Unveils ‘World’s Fastest Production Car’ and Electric Big Rig
- Norway Idea to Exit Oil Stocks Is ‘Shot Heard Around the World’
- Getting a Dog May Save Your Life, Especially If You’re Single
- The Questionable Math Behind Manafort’s Extravagant Home Renovations
- Honda Recalls 800,000 Odyssey Minivans Linked to Injuries